Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
24.03
-0.31 (-1.27%)
Mar 5, 2026, 9:38 AM EST - Market open
Olema Pharmaceuticals Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Olema Pharmaceuticals stock have an average target of 42, with a low estimate of 20 and a high estimate of 60. The average target predicts an increase of 74.78% from the current stock price of 24.03.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Olema Pharmaceuticals stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 5 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +99.75% | Feb 11, 2026 |
| UBS | UBS | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +87.27% | Jan 7, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $21 → $60 | Strong Buy | Maintains | $21 → $60 | +149.69% | Dec 12, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $45 → $48 | Buy | Maintains | $45 → $48 | +99.75% | Dec 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $26 → $38 | Strong Buy | Maintains | $26 → $38 | +58.14% | Dec 11, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
6.36M
EPS This Year
-1.91
from -2.20
EPS Next Year
-2.31
from -1.91
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | 58.9M | ||||
| Avg | n/a | 6.4M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.89 | -1.88 | ||||
| Avg | -1.91 | -2.31 | ||||
| Low | -1.90 | -2.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.